Shahriar Zehtabchi1, Robert Silbergleit2, James M Chamberlain3, Shlomo Shinnar4, Jordan J Elm5, Ellen Underwood5, Eric S Rosenthal6, Thomas P Bleck7, Jaideep Kapur8. 1. Department of Emergency Medicine, State University of New York, Downstate Health Sciences University, Brooklyn, New York, U.S.A. 2. Department of Emergency Medicine, The University of Michigan, Ann Arbor, Michigan, U.S.A. 3. The Division of Emergency Medicine, Children's National Medical Center, Washington, DC, U.S.A. 4. Departments of Neurology, Pediatrics and Epidemiology and Population Health, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, U.S.A. 5. Department of Public Health Sciences, Medical University of South Carolina, Charleston, South Carolina, U.S.A. 6. Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, U.S.A. 7. Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, U.S.A.; and. 8. Department of Neurology, University of Virginia, Charlottesville, Virginia, U.S.A.
Abstract
PURPOSE: It is unknown how often and how early EEG is obtained in patients presenting with status epilepticus. The Established Status Epilepticus Treatment Trial enrolled patients with benzodiazepine-refractory seizures and randomized participants to fosphenytoin, levetiracetam, or valproate. The use of early EEG, including frequency of electrographic seizures, was determined in Established Status Epilepticus Treatment Trial participants. METHODS: Secondary analysis of 475 enrollments at 58 hospitals to determine the frequency of EEG performed within 24 hours of presentation. The EEG type, the prevalence of electrographic seizures, and characteristics associated with obtaining early EEG were recorded. Chi-square and Wilcoxon rank-sum tests were calculated as appropriate for univariate and bivariate comparisons. Odds ratios are reported with 95% confidence intervals. RESULTS: A total of 278 of 475 patients (58%) in the Established Status Epilepticus Treatment Trial cohort underwent EEG within 24 hours (median time to EEG: 5 hours [interquartile range: 3-10]). Electrographic seizure prevalence was 14% (95% confidence interval, 10%-19%; 39/278) in the entire cohort and 13% (95% confidence interval, 7%-21%) in the subgroup of patients meeting the primary outcome of the Established Status Epilepticus Treatment Trial (clinical treatment success within 60 minutes of randomization). Among subjects diagnosed with electrographic seizures (39), 15 (38%; 95% confidence interval, 25%-54%) had no clinical correlate on the video EEG recording. CONCLUSIONS: Electrographic seizures may occur in patients who stop seizing clinically after treatment of convulsive status epilepticus. Clinical correlates might not be present during electrographic seizures. These findings support early initiation of EEG recordings in patients suffering from convulsive status epilepticus, including those with clinical evidence of treatment success.
PURPOSE: It is unknown how often and how early EEG is obtained in patients presenting with status epilepticus. The Established Status Epilepticus Treatment Trial enrolled patients with benzodiazepine-refractory seizures and randomized participants to fosphenytoin, levetiracetam, or valproate. The use of early EEG, including frequency of electrographic seizures, was determined in Established Status Epilepticus Treatment Trial participants. METHODS: Secondary analysis of 475 enrollments at 58 hospitals to determine the frequency of EEG performed within 24 hours of presentation. The EEG type, the prevalence of electrographic seizures, and characteristics associated with obtaining early EEG were recorded. Chi-square and Wilcoxon rank-sum tests were calculated as appropriate for univariate and bivariate comparisons. Odds ratios are reported with 95% confidence intervals. RESULTS: A total of 278 of 475 patients (58%) in the Established Status Epilepticus Treatment Trial cohort underwent EEG within 24 hours (median time to EEG: 5 hours [interquartile range: 3-10]). Electrographic seizure prevalence was 14% (95% confidence interval, 10%-19%; 39/278) in the entire cohort and 13% (95% confidence interval, 7%-21%) in the subgroup of patients meeting the primary outcome of the Established Status Epilepticus Treatment Trial (clinical treatment success within 60 minutes of randomization). Among subjects diagnosed with electrographic seizures (39), 15 (38%; 95% confidence interval, 25%-54%) had no clinical correlate on the video EEG recording. CONCLUSIONS: Electrographic seizures may occur in patients who stop seizing clinically after treatment of convulsive status epilepticus. Clinical correlates might not be present during electrographic seizures. These findings support early initiation of EEG recordings in patients suffering from convulsive status epilepticus, including those with clinical evidence of treatment success.
Authors: Jaideep Kapur; Jordan Elm; James M Chamberlain; William Barsan; James Cloyd; Daniel Lowenstein; Shlomo Shinnar; Robin Conwit; Caitlyn Meinzer; Hannah Cock; Nathan Fountain; Jason T Connor; Robert Silbergleit Journal: N Engl J Med Date: 2019-11-28 Impact factor: 91.245
Authors: Alexis A Topjian; Ana M Gutierrez-Colina; Sarah M Sanchez; Robert A Berg; Stuart H Friess; Dennis J Dlugos; Nicholas S Abend Journal: Crit Care Med Date: 2013-01 Impact factor: 7.598
Authors: Jan Claassen; David Albers; J Michael Schmidt; Gian Marco De Marchis; Deborah Pugin; Christina Maria Falo; Stephan A Mayer; Serge Cremers; Sachin Agarwal; Mitchell S V Elkind; E Sander Connolly; Vanja Dukic; George Hripcsak; Neeraj Badjatia Journal: Ann Neurol Date: 2014-05-16 Impact factor: 10.422
Authors: Paula A Gerber; Kevin E Chapman; Steve S Chung; Cornelia Drees; Rama K Maganti; Yu-Tze Ng; David M Treiman; Andrew S Little; John F Kerrigan Journal: J Clin Neurophysiol Date: 2008-10 Impact factor: 2.177
Authors: Eric T Payne; Xiu Yan Zhao; Helena Frndova; Kristin McBain; Rohit Sharma; James S Hutchison; Cecil D Hahn Journal: Brain Date: 2014-03-04 Impact factor: 13.501
Authors: Shahriar Zehtabchi; Samah G Abdel Baki; Ahmet Omurtag; Richard Sinert; Geetha Chari; Gholamreza S Roodsari; Jeremy Weedon; André A Fenton; Arthur C Grant Journal: Acad Emerg Med Date: 2014-03 Impact factor: 3.451